Moderna to Present at Upcoming Conferences in March 2026
Moderna (Nasdaq:MRNA) will present at two investor conferences in March 2026.
Rhea-AI Summary
Moderna (Nasdaq:MRNA) will present at two investor conferences in March 2026. Presentations are scheduled for TD Cowen 46th Annual Healthcare Conference on March 3, 2026 at 1:50 PM ET and Barclays 28th Annual Global Healthcare Conference on March 10, 2026 at 9:30 AM ET.
A live webcast will be available under Events and Presentations in the Investors section at investors.modernatx.com, with replays archived for at least 30 days after each presentation.
Positive
- None.
Negative
- None.
Details
News Market Reaction – MRNA
In the Feb 19 session, MRNA gained 6.65%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- TD Cowen conference number
- 46th
- TD Cowen 46th Annual Healthcare Conference
- TD Cowen date
- March 3rd
- TD Cowen conference presentation date
- TD Cowen time
- 1:50pm ET
- Scheduled presentation time at TD Cowen conference
- Barclays conference number
- 28th
- Barclays 28th Annual Global Healthcare Conference
- Barclays date
- March 10th
- Barclays conference presentation date
- Barclays time
- 9:30am ET
- Scheduled presentation time at Barclays conference
- Webcast replay period
- 30 days
- Minimum period replays will be archived on Moderna’s website
- Price change
- 6.08%
- 24h move in MRNA prior to this news
Historical Context
-
FDA accepted BLA for mRNA-1010 with PDUFA goal date set.
-
EU marketing authorization for COVID-19 vaccine mNEXSPIKE.
-
Q4/FY 2025 results with losses but cost cuts and 2026 growth plan.
-
FDA Refusal-to-File for mRNA-1010 BLA due to comparator choice.
-
Five-year strategic agreement with Mexico for vaccines and tech transfer.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / February 19, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
TD Cowen 46th Annual Healthcare Conference, on Tuesday, March 3rd at 1:50pm ET
Barclays 28th Annual Global Healthcare Conference, on Tuesday, March 10th at 9:30am ET
A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.